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Abstract
Background: The aim of this prospective registry was to determine the feasibility, safety, and
outcomes of percutaneous transluminal angioplasty and thrombolysis in the treatment of critical
hand ischemia (CHI).
Methods: One-hundred one patients (aged 60.6 ± 15.3 years) were treated for CHI between 2012
and 2016 in three cardiovascular centers. Anatomically, the upper arm was divided into three seg-
ments (I-subclavian, II-brachial, and III-forearm). We examined the rates of technical and clinical suc-
cess, major adverse events (MAEs), and vascular complications at 1 year and at long-term follow-up.
Results: Nineteen patients (18.8%) were treated for acute CHI, and 82 (81.2%) for chronic CHI.
Median follow-up was 36.9 (19.6–68.3) months. Clinical symptoms were isolated rest pain in
91 patients (90.1%) and digital ulcer or gangrene in 10 patients (9.9%). The technical and clinical
success rate of intervention was 96.0% (97/101) and 84.2% (85/101) at 1 year. Angioplasty was
performed in Segments I, II, and III in 28 (27.7%), in 29 (28.7%), and 44 (43.5%) patients. Stent
implantation was necessary in 47 patients (46.8%). Vascular access site complications were
found in 2.1% of the sample. After 1 year, MAEs occurred in 27 patients (26.9%), and the target
lesion revascularization rate was 11.9%. In two patients (1.9%), thoracic sympatectomy was nec-
essary, and two patients (1.9%) underwent minor finger amputations.
Conclusions: Angioplasty of hand vessels for CHI is a feasible and safe procedure with accept-
able rates of technical success and hand healing. MAEs are frequent because the rate of severe
comorbidities is high.
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1 | INTRODUCTION
Upper extremity arterial disease (UEAD) is a rare disease because ather-
erosclerosis is approximately 20 times less common in the arms than
in the legs and is usually limited to the proximal or inflow arteries.
Clinically, it can be manifested in upper extremity claudication or criti-
cal hand ischemia (CHI) with rest pain, ulceration, and gangrene. CHI
is either acute (aCHI) or chronic (cCHI), determined by characteris-
tics of disease onset. In the literature, only case reports1,2 and a lim-
ited number of studies about interventional treatment can be
found.3–6 The aim of this prospective study was to assess the long-
term feasibility, safety, and outcomes of percutaneous transluminal
angioplasty (PTA) and catheter-directed thrombolysis in the treat-
ment of CHI.
Abbreviations: BA, balloon angioplasty; CHI, critical hand ischemia; FA, femoral
access; GW, guidewire; RA, radial artery; RAO, radial artery occlusion; TR, transra-
dial; UA, ulnar artery; UEAD, upperextremityarterialdisease; US, duplex ultrasound.
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2 | METHODS
Patients with CHI were evaluated in a prospective study spanning three
cardio-vascular centers, and their clinical and angiographic data had
been analyzed. All patients underwent careful angiological examination,
vascular team consultation, diagnostic angiography, and vascular ultra-
sound before intervention. Patients who were candidates for surgical
revascularization were excluded from the study. The Institutional Ethi-
cal Review Committees approved the study in all three centers, and all
patients provided written informed consent prior to study inclusion.
Primary endpoints were the rates of technical success and major
adverse events (MAEs).
Secondary endpoints were clinical success, fluoroscopy time, X-ray
dose, procedural time, contrast consumption, duration of hospitaliza-
tion in days, and the rate of access-site complications.
Inclusion criteria were aCHI or cCHI associated with pain at rest
and/or ischemic hand lesions (finger gangrene or ulceration) and the
presence of hemodynamic significant lesions. A significant lesion was
defined as one with a diameter at least 50% that of the stenosis or
occlusion involving the subclavian, axillo-brachial, radial, ulnar, or
interosseous artery (the distal arches originating from the radial or
ulnar arteries were considered part of these arteries) or CHI after
transradial or transbrachial angioplasty.
Exclusion criteria were forearm claudication and subclavian steel
syndrome from subclavian artery stenosis, known thoracic outlet syn-
drome, Cimino Brescia fistulae at the ipsilateral site, and surgical
revascularization candidacy.
2.1 | Antithrombotic and thrombolytic regimen
After a loading dose of 325 mg aspirin and 300 mg clopidogrel,
patients underwent aspirin or clopidogrel monotherapy (100 mg aspi-
rin or 75 mg clopidogrel daily) in patients without stent implantation
and dual antiplatelet therapy for 2 months if a stent implantation was
present. Additional Na-heparin was given until reaching 100 IU/kg for
the procedure. Routine activated clotting time as not measured during
intervention.
Catheter directed thrombolysis was done with intra-arterial
recombinant tissue plasminogen activator (r-tPA; 10 mg bolus and
1 mg/h maintenance dose) and additional intravenous NaHeparin was
given to prevent catheter thrombosis (bolus 60 IU/kg, maintenance
dose 1,000 IU/h corrected by activated plasmin thromboplastin time).
2.2 | Access site selection
In aCHI, the access site for diagnostic angiography and for thromboly-
sis was the conventional femoral artery (FA).
In cCHI, primary access for angioplasty was via the FA method
when the lesion was proximal (Segments I–II), multiplex, or complex.
Where isolated, short lesions were below the elbow (BTE) (Segment
III), anterograde brachial artery access was preferred. Dual access site
was obtained in failed anterograde cases, using the distal radial (snuff-
box segment) or ulnar artery (UA) when the anterograde recanaliza-
tion failed. In some cases, the palmar arch technique was used as a
retrograde technique.1
2.3 | Angioplasty technique in cCHI
When FA access was used, the FA was punctured the conventional way,
and the subclavian artery was cannulated with a vertebral catheter. After
a selective angiography, a long hydrophilic sheath (90 cm, 6F, Cook Co.,
USA) was advanced in the subclavian artery proximal to the stenosis over
a long (260 cm) J-tip guidewire (GW). Subclavian and anonym artery
interventions were performed in routine clinical practice. When brachial
or BTE lesions were found, the stenosis was dilated with dedicated
below-the-knee balloons using a long inflation time, and stent implan-
tation was performed only when suboptimal results were reached
FIGURE 1 Angioplasty in chronic critical hand ischemia. A, High grade stenosis of the right ulnar artery (white arrow) in a patient with a chronic
renal failure and diabetes mellitus. B, The ulnar artery lesion after balloon angioplasty (white arrow)
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(Figure 1). Balloon expandable stents were used in short lesions, while
long lesions were stented with long self-expandable stents.
2.4 | Chronic total occlusion recanalization
Subclavian artery chronic total occlusion (CTO) recanalization was
performed using femoral access in the conventional way (Figure 2).
Brachial artery CTO recanalization was performed using a 0.018
guidewire and the penetration or subintimal technique (Figure 3).
Occlusions of the BTE artery were recanalized using 0.014 coronary
or with below-the-knee GWs 300 cm in length, applying the penetra-
tion or subintimal technique. Prolonged inflations were always used
with long, low-profile below-the-knee or coronary balloons, and stent
implantation was performed only when the lesions were flow limiting.
The anterograde recanalization was preferred for CTO, but after failed
anterograde attempts, recanalization was performed using a retro-
grade technique via the radial or UA. In some cases, the palmar arch
was used as a conduit (palmar arch technique, Figure 4).
2.5 | Angioplasty technique in aCHI
After selective angiography, the treatment strategy was different
depending on whether the thrombus burden was small or large. If it
was small, the patient underwent mechanical thrombectomy with a
thrombectomy catheter. If large, the patient underwent a local throm-
bolysis for 24 hr with local administration of r-tPA, and the angiogra-
phy was repeated after 24 hr. Additional thrombus aspiration was
performed if the thrombus remained flow limiting or occlusive after
thrombolysis, and additional balloon angioplasty was performed when
the lesion was significantly stenosed or dissected.
2.6 | Treatment of restenosis
Restenosis was treated with paclitaxel-eluting balloons using pro-
longed balloon dilatation. When the recoil was significant or the
lesions were flow-limiting, commercially available drug-eluting stents
were used (Figure 5).
2.7 | Postoperative treatment
When the FA approach was used in cCHI, the sheath was removed
immediately, and an Angio-Seal closure device (St Jude Medical) was
used. A mechanical compression bandage was used for 4 hr, and
patients were mobilized afterward. In patients with aCHI, the sheath
was removed only after discontinuation of r-tPA, and the FA site was
closed with Angioseal.
FIGURE 2 Subclavian artery CTO recanalization. A, Subclavian artery angiography from right radial artery access showing anonym artery CTO
(white arrow). B, The anonym artery CTO was passed with a Terumo wire, but balloon passage was unsuccessful, therefore the guidewire was
captured from femoral access and externalized (white arrow). C, The angioplasty was done from femoral approach, but the radial carotid artery
was protected from right radial access with a filter wire (white arrow). D, Balloon dilalation with a 6 × 40 mm balloon. E, Stent implantation with
a 10 × 29 mm Omnilink balloon expandable stent. E, Final angiography show good angiographic result (white arrow)
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When brachial artery access was used in cCHI, the sheath was
removed immediately, and hemostasis was achieved using a tourni-
quet for 6 hr. All patients were mobilized immediately.
When dual access was used, the distal ulnar access site was com-
pressed with dedicated compression device (RadiStop, Terumo, Japan)
obtaining patent hemostasis. The distal radial artery (RA) in the snuff-
box area was compressed manually for 5 min and thereafter tourni-
quet was used for 2 hr.
2.8 | Duplex ultrasound protocol
Duplex ultrasound was performed for all patients by a trained physi-
cian after the intervention and after 12 months. The diameter and the
peak systolic velocity of the RA and UA were measured at the wrist.
On the first postoperative day, the patency of the UA and RA was
evaluated by palpation, and vascular ultrasound as performed for
symptomatic patients or those with unpalpable RAs or UAs.
FIGURE 3 Brachial artery CTO recanalization. A, Brachial artery angiography shows a brachial artery CTO with highly developed collateral
system (white arrow). B, Final angiography after ballon dilatation (white arrow)
FIGURE 4 Local thrombolysis in acute hand ischemia. A, Brachial artery angiography of a patient with acute hand ischemia shows a total
occlusion of the axillary artery (white arrow). B, Control angiography after 24 hr local thrombolysis shoes good angiographic result (white arrow)
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FIGURE 5 Treatment of restenosis. A, Brachial artery repeat angiography after brachial artery angioplasty shows a critical restenosis (white
arrow). B, Control angiography after drug eluting balloon dilatation (Impact, Medtronic) shows no residual stenosis (white arrow)
FIGURE 6 The pathomechanism of CHI after transradial catheterization. A, Figure shows radial artery occlusion and incomplett or weak palmar
arch. B, Figure shows a radial artery occlusion beside ulnar artery chronic total occlusion. C, Figure shows a radial artery occlusion with distal
embolization or thrombus propagation [Color figure can be viewed at wileyonlinelibrary.com]
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2.9 | Quantitative angiography
Quantitative angiography and measurements were performed according
to standard clinical practice. Vessels and lesions were analyzed using a
computerized quantification system (Innova 3100; General Electric). The
arteries were localized as Segment I (anonym and subclavian artery),
Segment II (axillary and brachial artery), or Segment III (below-the-elbow
arteries, that is, ulnar, radial, and interosseal arteries and the palmar arch).
2.10 | Postprocedural follow-up
Access arteries were investigated physically and using duplex ultra-
sound after the procedure. All patients underwent detailed clinical
follow-up examinations at 2 and 12 months and on a long term after
the procedure.
2.11 | Definitions
2.11.1 | Major adverse event
An MAE was assessed as the composite of death, myocardial infarc-
tion, stroke, major upper arm amputation, and repeated revasculariza-
tion of the target vessel by PTA or by arterial bypass graft surgery at
2 months, 12 months, and on a long term.
2.11.2 | Definition of vascular complication
A major vascular complication was defined as diminished or lost arte-
rial pulse or the presence of any pseudo-aneurysm or arteriovenous
fistula during clinical follow-up. A minor complication was defined as a
hematoma requiring no further treatment, measuring ≤2 cm in diame-
ter over the radial or ulnar puncture area, or measuring ≤5 cm in diam-
eter over the femoral puncture site. Major bleeding was defined as a
fall in hemoglobin to more than 3 g/dL or any bleeding requiring a
blood transfusion.
2.11.3 | Technical success
A technical success was when PTA resulted in less than 30% residual
stenosis with sufficient anterograde flow. A suboptimal result was
characterized by sluggish flow and/or a residual stenosis between
30 and 50% after repeated dilatations.
2.11.4 | Clinical success
Primary clinical success was when an improvement of at least one
clinical category in the Rutherford-Becker classification7 was seen.
Primary patency was when persistent patency was seen without re-
intervention (angioplasty, surgery, or amputation) on or at the margins
of the treated lesion. Limb salvage was when the prevention of major
amputation was achieved. A finger amputation was classified minor,
whereas any amputation above that level was considered major.
2.11.5 | Contrast induced nepropathy
Contrast induced nepropathy was defined as an absolute ≥0.5 mg/dL
or a relative ≥25% increase in creatinine level at 24–72 hr after the
procedure without another clear cause for the acute kidney injury.
2.12 | Statistical analysis
Statistical analysis was performed using commercially available Graph
Pad Prism 6.0 software. Each continuous variable was expressed as
the mean ± standard deviation or as the median (inter-quartile range),
as appropriate. Each categorical variable was expressed as a percent-
age. The various patient cohorts were compared using either the
Mann–Whitney test or the Kruskal–Wallis test. Probability values not
exceeding 0.05 were considered significant.
3 | RESULTS
Nineteen patients (18.8%) with aCHI and 82 patients (81.2%) with
cCHI were treated. Clinical symptoms were isolated rest pain in
91 patients (90.1%) and digital ulcer or gangrene in 10 (9.9%). Demo-
graphic and clinical data are summarized in Table 1, while disease eti-
ology is summarized in Table 2.
3.1 | Anatomic and procedural data
Anatomic and procedural data are summarized in Tables 3 and 4.
Primary technical success (residual stenosis <30%) could be achieved in
96 patients (95.0%). Clinical success at 1 year was reached for
85 patients (84.2%). Single and dual access was obtained in 78 and
23 patients, respectively. The primary lesion was found in Segment I in
28 patients (27.7%), in Segment II in 29 (28.7%), and in Segment III in
TABLE 1 Demographic and clinical data of the study group patients
Acute CHI
n = 19, (%)
Chronic CHI
n = 82, (%)
All patients
n = 101 (%)
Age (years) 54.9 ± 21.3 62.4 ± 13.2 60.6 ± 15.3
Female 13 (68.4) 47 (57.3) 60 (59.4)
Hypertension 16 (84.2) 73 (89) 89 (88.1)
Hyperlipidemia 6 (31.5) 65 (79.2)* 71 (70.3)
Diabetes 3 (15.7) 30 (36.6)* 33 (32.7)
Smokers 9 (47.3) 54 (65.8)* 63 (62.4)
Renal failure 7 (36.8) 24 (29.2) 31 (30.7)
Coronary artery disease 5 (26.3) 37 (45.1)* 42 (41.6)
Atrial fibrillation (all type) 6 (31.5)* 15 (18.3) 21 (20.8)
Chronic obstructive
pulmonary disease
3 (15.8) 11 (13.4) 14 (13.8)
Raynaud syndrome 2 (10.5)* 2 (2.4) 4 (3.9)
Peripheral artery disease
(lower extremity)
11 (57.9) 57 (69.5) 68 (67.3)
*P < 0.05
TABLE 2 Etiology
Acute CHI
n = 19, (%)
Chronic CHI
n = 82, (%)
All patients
n = 101, (%)
Etiology
Atherosclerosis/thrombosis 7 (36.8) 59 (71.9) 66 (65.3)
Embolism 9 (47.3) 1 (1.2) 10 (9.9)
Trauma 2 (10.5) 1 (1.2) 3 (2.9)
Iatrogenic 0 (0) 18 (21.9) 18 (17.8)
Vasculitis 1 (0.5) 3 (3.7) 4 (3.9)
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44 (43.5%). In our sample of 101 patients, 133 lesions were treated,
and they were located in the anonym artery in 2 patients, the subcla-
vian artery in 28, the axillary artery in 15, the brachial artery in 27, the
RA in 35, the UA in 22, the interosseal artery in 1, the palmar arch in 4,
and the digital artery in 1 patient. Stent implantation was performed
for 47 patients (46.5%). Singular (n = 61, 60.4%), multilevel (n = 31,
30.7%), and parallel (n = 7, 6.9%) dilatations were performed. Throm-
bolysis and mechanical thrombectomy was performed for 55.5%
(11/19) and 47.4% (9/19), respectively in the 19 patients with aCHI.
Complete and partial thrombus resolution has been achieved in 3/11
(27.3%) and in 6/11 (54.5%) patients with large thrombus burden with
initial thrombolysis and additional thrombectomy and angioplasty was
necessary in 6/11 (54.5%) and 7/11 (63.6%) patients with 81.8% final
technical success. Complete thrombus resolution has been achieved in
8/8 (100%) patients with small thrombus burden with initial mechanical
thrombectomy (100%) and balloon angioplasty (100%) with 100% final
technical success.
Chronic total occlusion recanalization was performed for
49 patients, and a 95.9% success rate was achieved; however, dual
arterial access (femoral/brachial and distal radial/palmar arch) was
necessary in eight individuals (16.3%) because re-entry was unsuc-
cessful. Retrograde technique was obtained in 31 patients with a
93.5% successful result. Limb salvage was achieved in all patients
(100.0%). Major amputation was not necessary in any patient, but
additional distal finger amputations were performed in six patients
(5.9%) and thoracal sympetectomy in two patients (2%).
3.2 | Procedural complications
As indicated in Table 5, intraprocedural complications were not
observed, but one asymptomatic radial artery occlusion (RAO)
occurred after intervention. Contrast induced nepropathy was
detected in one patient, however the creatinine and carbamide nitro-
gen levels were normalized in 2 weeks. The rates of major and minor
vascular access complications were 2.9% (three brachial pseudoaneur-
ysm) and 2.0% (two femoral hematoma), respectively.
3.3 | One year and long-term follow-up
As shown in Table 5 and Figures 7 and 8, median follow-up was 36.9
(19.6–68.3) months. The MAE rate at 1 year and after long-term
follow-up was 26.9 and 45.0%, respectively. Similarly, the mortality
rate was 10.9 and 21.8%, respectively. Major amputation was not
observed in the investigated population, but minor amputations were
necessary in two patients (2.0%). The reintervention rate at 1 year
and 3 years was 11.9 and 18.3%, respectively.
3.4 | Repeat angiography
Angiography was repeated for 21 (20.8%) patients at long-term
follow-up, revealing restenosis or reocclusion in all cases. The clinically
driven restenosis rate was 14.3% in Segment I, 24.1% in Segment II,
and 27.3% in Segment III, while the restenosis rate after balloon
angioplasty or stent implantation was 12.8 versus 9.3% (p = ns) at
1 year follow-up. Stent or balloon restenosis rate was 9 versus 16.6%
in Segment I (p = ns), 23.1 versus 12.5% in Segment II (p < 0.05), and
TABLE 3 Angiographic data
Angiographic data
Segment I
(n = 28)
Segment II
(n = 29)
Segment III
(n = 44)
Diameter stenosis (%) 84.64 ± 16.88 95.86 ± 8.24 91.14 ± 23.25
Reference
diameter (mm)
7.53 ± 1.23 5.32 ± 1.45 2.75 ± 0.60
Chronic total
occlusion (n)
4 (12.5%) 8 (27.75%) 24 (54.54%)
Lesion length (mm) 31.5 ± 16.77 81.21 ± 63.58 80.52 ± 78.91
Severe calcification (n) 24 (85.7%) 11 (37.93%) 21 (47.72%)
Intraluminary
thrombus (n)
0 (0%) 10 (34.48%) 9 (20.45%)
Angiographic outcome
Successful 28 (100%) 28 (96.5%) 41 (93.2%)
Unsuccessful 0 (0%) 1 (3.5%) 3 (6.8%)
TABLE 4 Procedural data
Access n (%)
Single access (n = 78, 77.2)
Femoral 41 (52.6)
Anterograde brachial/ axillary 16 (20.5)
Radial or ulnar 21 (26.9)
Dual access (n = 23, 22.8)
Femoral + radial or ulnar 13 (56.5)
Femoral + brachial 4 (17.4)
Brachial + radial or ulnar 3 (13)
Radial + contralateral radial 3 (13)
Intervention
Balloon angioplasty 93 (100)
Stent implantation by patients 47 (46.5)
Stent implantation by segments
Segment I 22 (78.6%)
Segment II 13 (44.8%)
Segment III 14 (31.8%)
Aspiration thrombectomy 12 (11.9)
Thrombolysis 11 (10.9)
Equipments per procedure
Guidewire 2.2
Balloon 1.6
Stent 0.58
Procedural factors
Contrast consumption (mL) 142.7 [125.8–159.6]
X-ray dose (Gy/cm2) 331.2 [86.0–576.4]
TABLE 5 Complications
1 year FU
n (%)
3 years FU
n (%)
Myocardial infarction 2 (2.1) 8 (10.0)
Stroke 5 (5.2) 7 (8.0)
Major unplaned amputation 0 (0) 0 (0)
Re-angioplasty or bypass 11 (11.9) 15 (18.3)
Death 11 (10.9) 20 (21.8)
Major adverse event 27 (26.9) 42 (45.0)
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14.3 versus 13.3% in Segment III (p = ns) at 1 year follow-up, but the
long-term results were statistically significant in Segment I only (13.6
vs. 50%; p < 0.05). Reintervention achieved good angiographic and
clinical results for all patients (n = 21, 100.0%). Re-restenosis after a
successful procedure was achieved in 2 of 20 patients (10.0%).
4 | DISCUSSION
Pathophysiologically, UEADs can be divided into large artery (proximal to
the wrist) and small artery (distal to the wrist) diseases, and the primary
cause can be classified into thromboembolic (embolism and thrombosis),
atherosclerotic (large and small artery disease), or vasospastic disease.
Independently of pathophysiology, the end-stage of UEAD is CHI with
rest pain, ulceration, and gangrene.
The etiology of aCHI is mostly thromboembolic, and the emboli
of the digits can originate from the heart or from the upper arm arter-
ies. Additional radial an UA trauma, usually from intrarterial lines or
after transradial catheterization, leads to thrombosis and/or embolism
to distal digital arteries. Acute ischemia requires emergency surgical
intervention, but embolectomy of the distal arteries has many limita-
tions or can be impossible. Immediate administration of Na-heparin to
prevent thrombus propagation and urgent angiography is necessary in
these cases. Local thrombolytic therapy was published in some case
reports and original papers with good angiographic and clinical
results6,8–10 with using streptokinase, urokinase, and r-tPA in different
FIGURE 7 Major adverse events. A, Major adverse events. B, Myocardial infarction. C, Stroke. D, Target lesion revascularization
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studies. In a recent publication, A. M. Schrijver et al. achieved >95%
clot lysis in 61% of patients with the need of 35% additional angio-
plasty, with final 98% technical, 68% clinical success and an amputa-
tion rate of 7%,8 while in our study population the success depended
by initial thrombus burden. In patients with large thrombus burden
thrombolysis was fully or partially effective 9/11 patients (81.8%) and
in patients with small thrombus burden, thrombectomy was effective
in 8/8 patients (100%); however, the need of additional angioplasty
was high in both patient groups (63.6 vs 100%). Final clinical success
has been achieved in all patients and amputation was not necessary in
any patient.
The etiology of cCHI is quite variable, and the causes can be ath-
erosclerosis, thoracic outlet syndrome, vasculitis, autoimmune disease,
hypothenar hammer syndrome, iatrogenic calciphylaxis, or vasospasm.
Large artery occlusions in upper extremity circulation requires treat-
ment, either open or endovascular, because they cause hand claudica-
tion or CHI. The proximal inflow lesions (subclavian or anonym artery)
can be treated with angioplasty and stenting with good long-term
results,11 but the endovascular treatment of brachial or below-the-
elbow lesions has limited long-term evidence. Ferraresi et al. showed
that isolated below-the-elbow lesions can be treated with an 82%
technical success rate and hand healing up to 65%.4 The clinical reste-
nosis rate was found to be 18% after a half year, and 36% of the
patients died during follow-up. Our results show a 96.0% technical
success rate, and mortality and TLR rates after 1 year were 10.9 and
11.9%, respectively.
4.1 | RAO after transradial angioplasty
RA access for percutaneous intervention is associated with very low
major vascular complication rates in general, but the frequency of
RAO remains relatively high, though it has no clinical importance in
most cases because there is collateral formation from the interosseal
artery or the palmar arch.7,12 Possible mechanisms involved in occlusion
of the RA after transradial catheterization can be thrombus formation
after vessel injury (dissection, prolonged spasm, and hematoma),
occlusive compressure bandage, and distal embolization. When symp-
tomatic RAO was accompanied by CHI, conservative treatment is not
adequate, and invasive treatment with angioplasty should be consid-
ered. The data in the literature are very limited regarding long-term
results in this patient subgroup, and only case reports exist.1,2 Our
patient group consisted of 15 symptomatic patients after transradial
angioplasty; all had rest pain and one patient also had a digital ulcer.
This group was treated successfully with BA (15/15) and additional
stenting (3/15) with good clinical improvement (15/15), but the rein-
tervention rate at 1 year was 40.0% (two with stent thrombosis and
four with restenosis). The cause of the hand ischemia after transradial
intervention was radial artery occlusion beside week palmar arch (5/15
pts.), radial artery occlusion and ulnar artery stenosis (9/15 pts.) and
radial artery occlusion with distal embolisation (1/15 pts.). Figure 6 rep-
resents the possible cause of the hand ischemia after transradial cathe-
terization. Balloon angioplasty can be performed anterogradely via the
brachial or femoral approach, and retrogradely via the palmar arch or
distally from the occlusion site.
CTO recanalization can be luminal or subintimal. The luminal
recanalization technique is generally successful in short occlusions,
but is rarely effective in long occlusions, where subintimal angioplasty
is mandatory. The rationale of using subintimal angioplasty is to create
a subintimal lumen with the GW, and after proper BA, the new subin-
timal space is maintained open by blood pressure. The technique has
promising long-term results in the femoro-popliteal and infra-inguinal
tract,10,11 but only limited data for the below-the-elbow segment
is available.
4.2 | Study limitation
The primary limitation of this study is the lack of angiographic control
in all patients.
FIGURE 8 Survival. A, Cumulative survival. B, Survival in chronic and acute critical limb ischemia
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5 | CONCLUSIONS
Angioplasty of the hand vessels for CHI is a feasible and safe proce-
dure with acceptable rates of technical success and hand healing.
MAEs are frequent because of a high rate of severe comorbidities.
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